Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - December 2024

Click here to read the articles and download the PDF

Did Industry Fumble the DSCSA Deadline?

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Going Inside the Gross-to-Net Bubble and Its Nuances

A crash course on the bubble itself, including therapeutic areas most affected.

Why AI Advances in CGT Require Getting Data Right

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Pharma.Aero Welcomes Six New Members to Its Roster

February 07, 2024

DB Schenker, JAS, Medista, MSC Air Cargo, OnAsset Intelligence, and xpd global round out the latest additions.

Exploring the Frequency That Beneficiaries Encounter Subsidy Losses Attributed to Medicare Part D’s Low-Income Subsidy Program

February 07, 2024

Cohort study dives into whether low income subsidy losses are associated with disability status, age, and race and ethnicity.

Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business Models

February 07, 2024

The era of big pharma as product-first companies must end, as services become the larger priority.

Novel ADC in Trials for Ovarian, Fallopian Tube, Primary Peritoneal Cancers Gets FDA Fast Track Designation

February 06, 2024

BioNTech SE and Duality Biologics Co's BNT325/DB-1305 is a next-generation antibody-drug conjugate that targets the TROP2 protein, which is overexpressed across various tumor types.

FDA to Review Application to Expand Indication of RSV Vaccine Arexvy to Adults Aged 50-59 Years

February 06, 2024

Arexvy was the first FDA-approved respiratory syncytial virus (RSV) vaccine to prevent lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

December Air Freight Demand Rallies to End the Year

February 06, 2024

The air cargo market numbers close out the year slightly below 2022’s performance.

The Value of 3PLs

February 06, 2024

The February issue is centered around third-party logistics providers, including new dynamics and future trends that affect this key supply chain link.

The Correlation Between a New York State Law Repeal and Vaccine Coverage in Schools

February 06, 2024

A cohort study investigates the impact of Senate Bill 2994A and answers the question: does the repeal of school-entry nonmedical vaccination exemptions result in a rise in school vaccinations?

New Year, New Aspirations

February 06, 2024

Pharma Commerce's new style is built off of the back of our new and improved editorial calendar.

FDA Grants Fast Track Designation to Cancer Vaccine for Malignant Pleural Mesothelioma

February 05, 2024

UV1 is an off-the-shelf vaccine that has demonstrated a survival benefit in combination with ipilimumab (Yervoy) and nivolumab (Opdivo) in patients with unresectable malignant pleural mesothelioma.